BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11504489)

  • 1. Chloroquine - some open questions on its antimalarial mode of action and resistance.
    Ginsburg H; Krugliak M
    Drug Resist Updat; 1999 Jun; 2(3):180-187. PubMed ID: 11504489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered binding of chloroquine to ferriprotoporphyrin IX is the basis for chloroquine resistance.
    Raynes KJ; Bray PG; Ward SA
    Drug Resist Updat; 1999 Apr; 2(2):97-103. PubMed ID: 11504477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the amodiaquine-FPIX mu oxo dimer solution complex at atomic resolution.
    de Dios AC; Casabianca LB; Kosar A; Roepe PD
    Inorg Chem; 2004 Dec; 43(25):8078-84. PubMed ID: 15578847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs.
    Fitch CD
    Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structures of antimalarial drug-heme complexes.
    Leed A; DuBay K; Ursos LM; Sears D; De Dios AC; Roepe PD
    Biochemistry; 2002 Aug; 41(32):10245-55. PubMed ID: 12162739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical basis for the ferriprotoporphyrin IX-chloroquine complex induced lipid peroxidation.
    Sugioka Y; Suzuki M
    Biochim Biophys Acta; 1991 May; 1074(1):19-24. PubMed ID: 2043670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of action of chloroquine and related malarial schizontocides.
    Parasitol Today; 1986 Dec; 2(12):329. PubMed ID: 15462753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
    van Schalkwyk DA; Egan TJ
    Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily.
    Martin RE; Kirk K
    Mol Biol Evol; 2004 Oct; 21(10):1938-49. PubMed ID: 15240840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.
    Kuhn Y; Rohrbach P; Lanzer M
    Cell Microbiol; 2007 Apr; 9(4):1004-13. PubMed ID: 17381432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance.
    Hayward R; Saliba KJ; Kirk K
    J Cell Sci; 2006 Mar; 119(Pt 6):1016-25. PubMed ID: 16492710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
    Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
    Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine resistance and the pH of the malaria parasite's digestive vacuole.
    Kirk K; Saliba KJ
    Drug Resist Updat; 2001 Dec; 4(6):335-7. PubMed ID: 12030781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus.
    Li GD
    Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena.
    Ursos LM; DuBay KF; Roepe PD
    Mol Biochem Parasitol; 2001 Jan; 112(1):11-7. PubMed ID: 11166382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the anti-malaria active agent chloroquine under physiological conditions.
    Frosch T; Schmitt M; Bringmann G; Kiefer W; Popp J
    J Phys Chem B; 2007 Feb; 111(7):1815-22. PubMed ID: 17256887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
    Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
    Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.